Atlas Trials

The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein

Clinical trial NCT02562183 · UNKNOWN

Trial details

NCT number
NCT02562183
Sponsor
Techpool Bio-Pharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cerebral Infarction
Start date
2015-08-01
Primary completion
2018-11-30
Enrollment
2186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.